Daulton Varsho placed on the 10-day IL with a Grade 1 hamstring strain
Some clarity on Daulton Varsho's left hamstring injury was provided in the hours leading up to Sunday's series finale against the visiting Athletics.
What's clear is that the Jays will miss Varsho's presence in the outfield and at the plate, regardless of whatever rotation the club cares to use moving forward in his absence.
By moving Varsho to the 10-day injured list, a key piece has effectively been removed from the roster.
The exact timeline for a return remains very much up in the air.
Per manager John Schneider, Varsho suffered a Grade 1 strain during Saturday's win when he crushed a ball high off the wall in left field, this after George Springer had just hit a home run.
As Varsho rounded the bag at second base hoping to stretch it into a triple, he grabbed the back of his left leg.
He tried to one-hop it to third base, but was tagged out.
Once Varsho pulled up on the bases, the Jays' dugout turned silent.
There's been nothing silent about the way Varsho plays, one of the very few who leaves everything out on the field no matter the score or time in the game.
The plan is to evaluate Varsho on a week-to-week basis.
A Grade 1 strain is considered the mildest version, but soft tissue injuries are delicate and it would be surprising to see Varsho back in the lineup this month.
The Jays' injury list is beginning to overflow, a group that includes Anthony Santander, Yimi Garcia, Max Scherzer, Andres Gimenez, Tyler Heineman and Nick Sandlin.
At least Erik Swanson was activated off the IL Sunday, a move many expected given his presence in the clubhouse Saturday.
Gimenez is the next candidate to be activated as early as Tuesday when the Phillies come to town for a three-game series.
Swanson has yet to appear in a game this season.
Varsho began the season inactive following his off-season shoulder surgery and subsequent rehab.
In his absence, the Jays used this three-man rotation in centre field featuring Myles Straw, Nathan Lukes and George Springer.
Varsho's latest absence will open the door for extended playing time in centre for Lukes and Straw.
Straw entered Saturday's game in the wake of Varsho's injury and started in centre in Sunday's series finale as the Jays attempted to complete their four-game sweep.
Not having Varsho in the lineup also presents an opportunity for the likes of Jonatan Clase and Alan Roden.
Once Varsho was placed on the 10-day IL, it allowed the Jays to recall Davis Schneider, who started Sunday's game at second base.
The move to activate Swanson off the IL meant Easton Lucas had to be optioned to Triple-A Buffalo.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
4 Supplements You Shouldn't Take for Gut Health, According to Dietitians
Reviewed by Dietitian Jessica Ball, M.S., RDSome gut health supplements lack research and may do more harm than good. Experts recommend food first: fiber, fermented foods and variety support your microbiome. Always talk to a health care professional before trying OTC enzymes or health isn't just about good digestion. A healthy gut microbiome—the colony of bacteria and other microorganisms living in your intestines—is also important for immune health, heart health, brain health and more. The foods you eat can significantly impact the makeup of your gut microbiota, for better or worse. But what role do supplements play in gut health? Many supplements promise to heal your gut, but research does not support many of these claims. We spoke to nutrition experts to find out what you should and shouldn't do for gut health. Registered dietitians encourage a food-first approach instead of relying on expensive, unregulated supplements. Read on to see which ones they say to skip. Probiotic supplements often claim to improve health by restoring healthy gut bacteria and some research suggests they may help reduce the symptoms of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). 'For probiotics to be effective, you need to take the right strain at the right dose for your condition. Probiotics may worsen symptoms in many people with small intestinal bacterial overgrowth (SIBO),' says Kerry Conlon, M.S., RD. According to Kelsey Costa, M.S., RDN, most people can 'cultivate a healthy gut microbiome by engaging in regular exercise and consuming a diet rich in whole, minimally processed foods.' Since they are supplements, the Food and Drug Administration does not regulate probiotics. Over-the-counter probiotics available in pharmacies and stores may not be high quality, and it's even possible that some products may not contain the probiotic bacteria listed on the label. Many greens powders claim to improve gut and overall health; however, there isn't much research to back up these claims. One thing most greens powders don't provide is dietary fiber. Conlon says, 'Relying on powders for nutrients instead of whole fruits and vegetables deprives your body of fiber, an essential nutrient for gut health.' Fiber feeds beneficial gut bacteria and promotes digestion and nutrient absorption. Over-the-counter digestive enzymes are often thought to relieve acid reflux, gas and bloating. The market for these products is substantial, but it's not known if they are safe or effective since they are unregulated by the FDA and limited research is available. The body naturally produces digestive enzymes to help break down food. 'Most people don't need to supplement with digestive enzymes unless they have certain medical conditions, like cystic fibrosis or liver problems,' explains Amanda Sauceda, M.S., RD. According to Costa, 'The precise ingredients, dosage and potency of digestive enzyme products could vary significantly without any guaranteed outcomes or firm understanding of potential side effects.' Costa recommends talking to your health care provider before taking OTC digestive enzymes. Even then, take only the specific enzyme supplements directed by your health care provider and watch for potential side effects. Antacids—an OTC remedy for treating heartburn, acid reflux and indigestion—work by neutralizing stomach acid, providing quick relief from discomfort. 'While antacids are technically medications and not supplements, they are widely available OTC and are overused by many,' says Costa. Research suggests that proton-pump inhibitors (PPIs)—a commonly used type of antacid—may significantly change the makeup of the gut microbiome. This may result in an overgrowth of harmful gut bacteria, changes in nutrient absorption and inappropriate immune responses. PPIs should only be used as needed, as directed by a health care provider. According to a recent review from Gut Microbes, polyphenols and probiotics found in fruits, vegetables, whole grains, legumes, nuts and seeds support gut health and the growth of good gut bacteria. For a healthy gut, focus on consuming a variety of plant-based foods while limiting foods high in added sugar and saturated fat. On your next shopping trip, Sauceda suggests picking up a fruit, veggie or grain you haven't had in a while. Aim to consume at least 25 grams of fiber daily and eat lots of fermented foods, like kefir, sauerkraut and kombucha. Fermented foods naturally contain probiotics that support gut health, while fiber feeds beneficial gut bacteria. Add a fruit, vegetable or whole grain to each meal and snack to help you hit your fiber goal. Gut health is best achieved through a healthy lifestyle including eating a balanced and variety-filled diet, regularly exercising, getting enough quality sleep and managing stress in a healthy way. Instead of spending money on expensive supplements that might not be effective, eat a balanced diet that is high in fiber and low in added sugars and saturated fats. Focus on including a variety of plant-based and fermented foods. Read the original article on EATINGWELL
NBC Sports
37 minutes ago
- NBC Sports
Yankees at Blue Jays Prediction: Odds, expert picks, starting pitchers, betting trends and stats for June 30
It's Monday, June 30 and the Yankees (47-35) are in Toronto to take on the Blue Jays (44-38). Carlos Rodón is slated to take the mound for New York against Max Scherzer for Toronto. Toronto is coming off a 5-3 win over Boston on Sunday and are 3-1 in the past four games. The Blue Jays are coming off a six-game road trip where they went 4-2 with a one-run extra inning loss. The Yankees followed up a 7-0 loss on Saturday with a 12-5 drumming of the Athletics on Sunday. Aaron Judge homered twice after going hitless in the first two games of the series. Let's dive into the matchup and find a sweat or two. We've got all the info and analysis you need to know ahead of the game, including the latest info on how to catch first pitch, odds, recent team performance, player stats, and of course, our predictions, picks & best bets for the game from our modeling tools and staff of experts. Follow Rotoworld Player News for the latest fantasy and betting player news and analysis all season long. Game details & how to watch Yankees at Blue Jays Date: Monday, June 30, 2025 Time: 7:07PM EST Site: Rogers Centre City: Toronto, ON Network/Streaming: YES, Sportsnet Never miss a second of the action and stay up-to-date with all the latest team stats and player news. Check out our day-by-day MLB schedule page, along with detailed matchup pages that update live in-game with every out. Odds for the Yankees at the Blue Jays The latest odds as of Monday: Moneyline: Yankees (-156), Blue Jays (+130) Spread: Yankees -1.5 Total: 8.0 runs Probable starting pitchers for Yankees at Blue Jays Pitching matchup for June 30, 2025: Carlos Rodón vs. Max Scherzer Yankees: Carlos Rodón, (9-5, 2.92 ERA) Last outing: 6.0 Innings Pitched, 0 Earned Runs Allowed, 4 Hits Allowed, 1 Walk, and 5 StrikeoutsBlue Jays: Max Scherzer, (0-0, 5.63 ERA) Last outing: 5.0 Innings Pitched, 3 Earned Runs Allowed, 6 Hits Allowed, 3 Walks, and 4 Strikeouts Yankees: Carlos Rodón, (9-5, 2.92 ERA) Last outing: 6.0 Innings Pitched, 0 Earned Runs Allowed, 4 Hits Allowed, 1 Walk, and 5 Strikeouts Blue Jays: Max Scherzer, (0-0, 5.63 ERA) Last outing: 5.0 Innings Pitched, 3 Earned Runs Allowed, 6 Hits Allowed, 3 Walks, and 4 Strikeouts Rotoworld still has you covered with all the latest MLB player news for all 30 teams. Check out the feed page right here on NBC Sports for headlines, injuries and transactions where you can filter by league, team, positions and news type! Expert picks & predictions for tonight's game between the Yankees and the Blue Jays Please bet responsibly. If you or someone you know has a gambling problem, call the National Gambling Helpline at 1-800-522-4700. Our model calculates projections around each moneyline, spread and over/under bet for every game on the MLB calendar based on data points like past performance, player matchups, ballpark information and weather forecasts. Once the model is finished running, we put its projection next to the latest betting lines for the game to arrive at a relative confidence level for each wager. Here are the best bets our model is projecting for Monday's game between the Yankees and the Blue Jays: Moneyline: NBC Sports Bet is recommending a play on the New York Yankees on the Moneyline. Spread: NBC Sports Bet is leaning towards a play ATS on the Toronto Blue Jays at +1.5. Total: NBC Sports Bet is recommending a play on the over on the Game Total of 8.0. Want even more MLB best bets and predictions from our expert staff & tools? Check out the Expert MLB Predictions page from NBC. Top betting trends & insights to know ahead of Yankees at Blue Jays The Blue Jays have lost their last 3 games against teams with better records The Yankees' last 6 matchups against AL East teams have gone under the Total The Blue Jays have covered in 4 of their last 5 games showing a profit of 1.78 units The Yankees were on a 16-0 run to the game total Under, but went Over yesterday in a 12-5 win versus the Athletics If you're looking for more key trends and stats around the spread, moneyline and total for every single game on the schedule today, check out our MLB Top Trends tool on NBC Sports! Follow our experts on socials to keep up with all the latest content from the staff: Jay Croucher (@croucherJD) Drew Dinsick (@whale_capper) Vaughn Dalzell (@VmoneySports) Brad Thomas (@MrBradThomas)
Yahoo
37 minutes ago
- Yahoo
2 Stocks That Have Doubled This Year and Are Still Worth Buying
TransMedics Group's innovative approach to storing organs for transplants grants it significant growth fuel. FuboTV's recent merger with a leading media company substantially improved its prospects. 10 stocks we like better than TransMedics Group › Positive, company-specific developments have led to shares of TransMedics Group (NASDAQ: TMDX) and FuboTV (NYSE: FUBO) more than doubling this year, even as the S&P 500 is barely in the green since January. Investing wisdom advises us to buy low, and some might think that after a greater than 100% return in six months, it's too late to get in on these stocks. However, TransMedics Group and FuboTV still have excellent prospects that could lead to better-than-average returns over the long run. TransMedics Group, a medical device specialist that developed an innovative method for storing organs for transplant, entered the year facing challenges. First, the company's guidance disappointed investors. Second, TransMedics was the subject of a short-seller report from Scorpion Capital, which made a series of serious allegations, including claims that TransMedics Group is engaged in organ trafficking. However, the company has performed well this year because of better-than-expected financial results. In the first quarter, TransMedics' revenue increased by 48% year over year to $143.5 million. The company's net earnings per share came in at $0.70, doubling compared to the year-ago period. To top it all off, TransMedics raised its guidance for the full fiscal year 2025. With results like these, even the short-seller report that sank its stock price now looks like a distant memory. The best part is that there is still considerable upside potential for TransMedics Group. The company's organ care system (OCS) technology aims to mimic the physiology of the human body, enabling the storage of organs for longer periods, which results in significantly higher usage rates compared to traditional cold storage methods. It's already hard enough to find available transplants. It's a shame if they go to waste due to poor storage. Thus, TransMedics Group is helping revolutionize the organ donation business thanks to its OCS, and there is plenty of room for growth. The company estimates organ donations will grow at a decent rate through the next few years, at least. Capturing a larger share of the market and improving utilization rates for existing organ donations -- even if there aren't more donors over time -- should lead to stronger financial results for TransMedics Group. That's why the stock remains a buy today, at least for investors willing to stay the course for a while, even after doubling in value already this year. In January, streaming specialist FuboTV announced it was merging with Disney's Hulu+ Live TV. The deal makes FuboTV far more attractive than it was before for several reasons. First, it helps diversify the company's offerings. FuboTV was known for its laser focus on sports streaming, a niche of the market that can be somewhat seasonal. Second, the deal came with the cancellation of the Venu initiative. Disney, Fox, and Warner Bros. Discovery were planning to launch a competing sports-focused streaming platform called Venu, which might have killed FuboTV altogether, considering the company's subscription growth rate had plummeted. Third, FuboTV got a nice infusion of cash as part of the deal. It got $220 million from the former backers of Venu. And that's on top of a $145 million term loan from Disney. Last but not least, Disney is now FuboTV's majority shareholder. The backing of a longtime successful media giant with equally successful ventures in the streaming niche will be of massive help to FuboTV. Yes, the stock has already skyrocketed this year, but considering the long-term opportunity in streaming, there should still be plenty of upside for FuboTV. Streaming accounted for 44.8% of television viewing time in May in the U.S., surpassing the combined share of broadcast and cable for the first time. Even so, that's in the U.S., one of the more penetrated markets. And even here, streaming likely hasn't peaked. That points to a massive whitespace worldwide. FuboTV will have to deal with stiff competition, but the company's new standing after the merger with Hulu+ Live TV -- and the backing of Disney -- should work wonders over the long run. That's why the stock is still a buy. Before you buy stock in TransMedics Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TransMedics Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends TransMedics Group, Walt Disney, Warner Bros. Discovery, and fuboTV. The Motley Fool has a disclosure policy. 2 Stocks That Have Doubled This Year and Are Still Worth Buying was originally published by The Motley Fool
